Invictus Therapeutics
PrivateLast Round
Grant
Jan 12, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Invictus Therapeutics is a biotechnology company developing next-generation insulin analogs engineered for automated insulin delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invictus Therapeutics Comparables
Compare Invictus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metabulin | 84% | |
| Arecor Therapeutics PLC | 75% | |
| Halozyme Therapeutics | 74% | |
Invictus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 12, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Received grant funding to support operations.
Invictus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Invictus Therapeutics's valuation, stock price, and market status.